Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
RETRANSMISSION: Manganese X Energy Corp. Underscores Urgency to Establish North American Battery Materials Supply Chain Due to China's Recent Export Controls on Critical Minerals
-
Prospector Defines Multiple Gold Trends at Skarn Ridge: Drilling Highlights Include: 61.45 g/t Au over 1.9m and 4.64 g/t Au over 10m; 2.97 g/t Au over 25m; and 141 g/t Au over 0.5m
-
Denarius Metals Receives Approval of Final Permit at Its Zancudo Project in Colombia and Is Commencing Construction of Its 1,000 Tonnes per Day Processing Plant to Begin Operations in Second Quarter o
-
Highway 50 Gold Corp. Expands Quito North Land Position and Advances Exploration at Nevada Projects
-
Sparq Announces Development of Duo Microinverter
-
Alto Neuroscience Announces Plans to Accelerate Development of ALTO-207 in Treatment Resistant Depression Following Successful Outcome from Recent FDA Meeting
-
1-800-Packouts offers expert guidance to help homeowners prepare for and recover from fires
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Signify share repurchase period update
-
IAMGOLD Signs Agreement to Acquire Mines D'Or Orbec Inc.
-
Schouw & Co. share buy-back programme, week 42 2025
-
Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt
-
Vivid Seats Announces Termination of Tax Receivable Agreement and Elimination of Dual-Class Stock Structure
-
Waco Corporation Launches Next-Generation Digital Water Purifiers 'IFev' and 'Apollo' Series
-
Driving the Future of School Bus Safety: First Student's HALO™ Technology Platform - Powered with Advanced AI Insights - Takes Center Stage at the NYSE
-
Generate Capital Secures C$60 million Financing from Fiera Infrastructure Private Debt for Upcycle, as RNG Momentum Builds Across North America
-
TIME Names AI Coach by Edthena a Best Invention of 2025
-
Freightos Reports KPIs for Third Quarter of 2025 Exceeding Management Expectations
-
Anecdotes Announces New Integration With AuditBoard to Bring Joint Customers Data-Driven Continuous GRC
-
Five Star Franchising ranked No. 6 on MountainWest Capital Network's Utah 100 list for 2025
-
Novo Nordisk to present new data in oral semaglutide 25 mg (Wegovy® in a pill*) and obesity pipeline at ObesityWeek® 2025
-
Coral reaches a 500k monthly workflow milestone as revenues scale 8x
-
CITY OF LONDON INVESTMENT GROUP PLC ("City of London" or "the Group" or "the Company" or "CLIG") TRADING UPDATE FOR THE QUARTER TO 30 SEPTEMBER 2025
-
HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025
-
Humber River Health Celebrates 10-Year Anniversary of Wilson Site
-
BioCryst to Report Third Quarter 2025 Financial Results on November 3
-
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
-
GoldMining Reports Initial Drill Results and Confirms Multiple New Mineralized Targets across São Jorge Project, Brazil
-
Westbridge Renewable Energy to Present at the Planet MicroCap Showcase in Toronto
-
BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease
-
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
-
Collective Mining Provides an Exploration Update: Significant Visual Mineralization Intersected in Expansion Drilling at Both the Guayabales and San Antonio Projects
-
RideCo and the City of Albuquerque's Transit Department Launch Innovative New On-Demand Transit Service
-
Harmony Whole Person Oral Healthcare Launches Integrated Oral Health Facility in Oakland
-
Miri Technologies to Unveil New Resilient Internet Platform and Upgrades to X510 Bonding Router at NAB Show New York
-
ST Engineering iDirect Announces General Availability of Intuition Ground System
-
Andel Raises $4.5M for Its Employer-Supported Medication Marketplace
-
Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at I
-
Tune in to Bloomberg TV on Saturday, October 25th to watch a New Episode of Advancements
-
Glaukos Announces FDA Approval of Epioxa™
-
Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025
-
Fanatec Powers Sim Racers with Launch of Highly Anticipated Products at SimRacing Expo 2025
-
Spanish Mountain Gold Initiates Ore Sorting Work on Gold Mineralization
-
Iambic Shares Clinical Data from Ph1/1B Study of IAM1363, a Highly Selective Type-2 HER2 Inhibitor, Demonstrating Monotherapy Activity in Heavily Pretreated Patients with HER2 Alterations, at the 2025
-
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
-
NPK International Announces Third Quarter 2025 Results Conference Call and Webcast Date
-
Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025
-
Old Dominion Freight Line, Inc. Announces General Rate Increase
-
Lattice Semiconductor Schedules Third Quarter 2025 Results Conference Call
-
KKR Launches Galaxy Container Solutions, A Global Container Leasing and Financing Platform
